Effect of cirrhosis on antibiotic efficacy in a rat model of pneumococcal pneumonia
Authors:
- Laurel C. PreheimLPLaurel C. Preheim
- Keith M. OlsenKOKeith M. Olsen
- Mei YueMYMei Yue
- Mary U. SnitilyMSMary U. Snitily
- Martha J. Gentry-NielsenMGMartha J. Gentry-Nielsen
- 28 February 2005
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 51 (2) , 103-111
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- The Effect of Clarithromycin on Inflammatory Markers in Chronic Obstructive Pulmonary Disease: Preliminary DataAnnals of Pharmacotherapy, 2004
- Community-acquired pneumoniaThe Lancet, 2003
- Efficacy of liposome-encapsulated ciprofloxacin compared with ciprofloxacin and ceftriaxone in a rat model of pneumococcal pneumonia.Journal of Antimicrobial Chemotherapy, 2002
- Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjectsEuropean Journal of Pharmacology, 2002
- Pharmacodynamics of Fluoroquinolones against Streptococcus pneumoniae in Patients with Community-Acquired Respiratory Tract InfectionsAntimicrobial Agents and Chemotherapy, 2001
- Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopyJournal of Antimicrobial Chemotherapy, 1997
- The chemistry and biological profile of trovafloxacinJournal of Antimicrobial Chemotherapy, 1997
- In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteriaAntimicrobial Agents and Chemotherapy, 1993
- Pulmonary disposition of antimicrobial agents: methodological considerationsAntimicrobial Agents and Chemotherapy, 1992
- Pneumococcal Bacteremia with Especial Reference to Bacteremic Pneumococcal PneumoniaAnnals of Internal Medicine, 1964